Over the past decade, funding for cancer research by the US government—and others—has stagnated, while the demand for investment has grown because of the increasing cancer incidence worldwide. We discuss how National Cancer Institute funding efforts have developed during this period, and the contemporary and future impact of these measures on cancer research in the USA.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cancer; an induced disease of twentieth century! Induction of tolerance, increased entropy and ‘Dark Energy’: loss of biorhythms (Anabolism v. Catabolism)
Clinical and Translational Medicine Open Access 02 July 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
American Society of Clinical Oncology. The Funding Crisis in Cancer Clinical Trials: A Focus on Cooperative Groups [online], (2014).
Institute of Medicine (US) Committee on Cancer Clinical Trials and the NCI Cooperative Group Program (eds Nass, S. J., Moses, H. L. & Mendelsohn, J.). A National Cancer Clinical Trials System for the 21st Century: Reinvigorating The NCI Cooperative Group Program (The National Academies Press, 2010).
National Cancer Institute at the National Institutes of Health. Clinical Trials Programs and Initiatives: An Overview of NCI's National Clinical Trials Network [online], (2014).
Seow, H.-Y. et al. Funding oncology clinical trials: are cooperative group trials sustainable? J. Clin. Oncol. 30, 1456–1461 (2012).
Begley, C. G. & Ellis, L. M. Drug development: raise standards for preclinical cancer research. Nature 483, 531–533 (2012).
Basner, J. E. et al. Measuring the evolution and output of cross-disciplinary collaborations within the NCI Physical Sciences–Oncology Centers Network. Res. Eval. 22, 285–297 (2013).
Varmus, H. & Harlow, E. Science funding: Provocative questions in cancer research. Nature 481, 436–437 (2012).
Benowitz, S. Provocative Questions initiative to fund innovative cancers research. J. Natl Cancer Inst. 104, 970–972 (2012).
Kaiser, J. Funding. NIH institute considers broad shift to people awards. Science 345, 366–367 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Fojo, T., Giannakakou, P. National Cancer Institute awards—a work in progress. Nat Rev Clin Oncol 11, 634–636 (2014). https://doi.org/10.1038/nrclinonc.2014.173
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2014.173
This article is cited by
-
Cancer; an induced disease of twentieth century! Induction of tolerance, increased entropy and ‘Dark Energy’: loss of biorhythms (Anabolism v. Catabolism)
Clinical and Translational Medicine (2018)
